Expression patterns of programmed death ligand 1 correlate with different microenvironments and patient prognosis in hepatocellular carcinoma

BACKGROUND: Recent clinical studies have suggested that programmed death ligand 1 (PD-L1) expression in a tumour could be a potential biomarker for PD-L1/PD-1 blockade therapies. METHODS: To better characterise PD-L1 expression in hepatocellular carcinoma (HCC), we analysed its expression patterns i...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chao-Qun, Xu, Jing, Zhou, Zhong-Guo, Jin, Li-Lian, Yu, Xing-Juan, Xiao, Gang, Lin, Jie, Zhuang, Shi-Mei, Zhang, Yao-Jun, Zheng, Limin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035200/
https://www.ncbi.nlm.nih.gov/pubmed/29921949
http://dx.doi.org/10.1038/s41416-018-0144-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035200/
https://www.ncbi.nlm.nih.gov/pubmed/29921949
http://dx.doi.org/10.1038/s41416-018-0144-4

Ejemplares similares